Plasma lipid profile: a predictive marker of disease severity among COVID-19 patients —an opportunity for low-income countries

ConclusionA routine lipid profile test might help as a marker of inflammation and risk stratification in patients with COVID-19. Especially in middle- or low-income countries, the test can rapidly help clinicians to delineate prognostic measures and hence management and treatment plans for this disease as the levels of the lipid profile were correlated with the patients ’ BMI and infection severity.
Source: Drugs and Therapy Perspectives - Category: Drugs & Pharmacology Source Type: research